BMJ  2006;333:270-271 (5 August), doi:10.1136/bmj.38929.647662.80

Editorial

Further lessons from the TGN1412 tragedy

New guidelines call for a change in the culture of research

The first 150 words of the full text of this article appear below.

As eight young men assembled at a London hospital on 13 March this year, they had no idea that within an hour their lives would be changed irrevocably and they would have contributed to a fundamental rethinking of the development and testing of new drugs. The first trial of TeGenero's TGN1412 (a T cell agonist) in humans took place at Parexel's clinical pharmacology research unit at Northwick Park Hospital, London. The events that followed fuelled speculation not only into the conduct of the trial and the nature of the drug, but also into aspects of research as diverse as comparative molecular biology, bioethics, and health economics.¹

The Medicines and Healthcare Products Regulatory Agency initiated an investigation, but the BMJ and other journals called for a more far reaching inquiry independent of the regulatory agency that had approved the trial. On 5 April the agency released its interim report,² and . . . [Full text of this article]

Division of Medical Oncology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada B3H 2Y9
(MGoodyear@dal.ca)

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

"We saw human guinea pigs explode"

L Stobbart, M J Murtagh, T Rapley, G A Ford, S J Louw, and H Rodgers
BMJ 2007 334: 566-567. [Extract] [Full Text] [PDF]

A model clinical trials agreement

Michael D E Goodyear
BMJ 2006 333: 1083-1084. [Extract] [Full Text] [PDF]

In brief
BMJ 2006 333: 276. [Extract] [Full Text] [PDF]

Rules for drug trials should be tightened, say experts

Zosia Kmietowicz
BMJ 2006 333: 276. [Extract] [Full Text] [PDF]

Learning from the TGN1412 trial

Michael Goodyear
BMJ 2006 332: 677-678. [Extract] [Full Text] [PDF]

Human error: models and management

James Reason
BMJ 2000 320: 768-770. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Lo, B., Kriegstein, A., Grady, D. (2008). Clinical trials in stem cell transplantation: guidelines for scientific and ethical review. Clin Trials 5: 517-522 [Abstract]  
• Goodyear, M. D E (2006). A model clinical trials agreement. BMJ 333: 1083-1084 [Full text]  

Rapid Responses:

Read all Rapid Responses

Ethics and Pharmaceutical Medicine - Faculty of Pharmaceutical Medicine Guidelines

Kathryn H Swanston
bmj.com, 8 Aug 2006 [Full text]

Online poll

Find out more >>